3 terminated. 3 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 1 | 2 | Terminated 2 |
| Phase 3 | 1 | Terminated 1 |
Follow fosbretabulin: new trials by email Literature Review of fosbretabulin trials Research Report on fosbretabulin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer Pazopanib, Fosbretabulin - Ovarian Neoplasms, Neoplasms, Ovarian | Phase 1 / Phase 2 | Terminated | The Christie NHS Foundation Trust | 21 | 2014-09-01 | 2021-05-17 |
| Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer CA4P, paclitaxel, carboplatin - Anaplastic Thyroid Cancer | Phase 2 / Phase 3 | Terminated | Mateon Therapeutics | 80 | 2007-08-01 | 2014-06-09 |
| Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer filgrastim, pegfilgrastim, cisplatin - Head and Neck Cancer | Phase 1 / Phase 2 | Terminated | Case Comprehensive Cancer Center | 4 | 2003-11-01 | 2010-06-11 |
Thyroid Carcinoma, Anaplastic (2) · Head and Neck Neoplasms (1) · Ovarian Neoplasms (1) · Thyroid Neoplasms (1)
Case Comprehensive Cancer Center (1) · Mateon Therapeutics (1) · The Christie NHS Foundation Trust (1)
United Kingdom (2) · United States (2) · Belarus (1) · Bulgaria (1) · Egypt (1) · India (1) · Israel (1) · Italy (1) · Poland (1) · Romania (1) · Russia (1) · Ukraine (1)
Gordon Jayson (1) · Gordon Rustin (1) · Julie A. Sosa, MD, FACS (1) · Panayiotis Savvides, MD (1)
P30CA043703 (1)